President Christine Lagarde signaled the European Central Bank will consider a possible interest-rate hike in June after policymakers debated and rejected the idea on Thursday.

“We made an informed decision on the basis of yet insufficient information,” Lagarde said. “We debated the decision that we have unanimously taken today, but we also debated at length, and in depth, a decision to possibly hike.”

This post was originally published on this site.

Avalyn Pharma Inc., a biopharma company developing inhaled treatments for rare lung diseases, raised $300 million in a US initial public offering that priced at the top of its marketed range.

The Boston-based company sold 16.7 million shares at $18 each, according to a statementBloomberg Terminal Wednesday. The firm had offered shares for $16 to $18 each, its filings showed.

This post was originally published on this site.